Tech Company Financing Transactions
Elixirgen Therapeutics Funding Round
Private investors participated in a $4 million Series A venture round for Elixirgen Therapeutics. The round was announced on 7/11/2018.
Transaction Overview
Company Name
Announced On
7/11/2018
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
855 N. Wolfe St. 619
Baltimore, MD 21205
USA
Baltimore, MD 21205
USA
Phone
Email Address
Overview
Elixirgen Therapeutics is a biotechnology company focused on curing humanity's ailments through stem cell biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Akihiro Ko
Chief Scientific Officer
Minoru Ko
Browse more venture capital transactions:
Prev: 7/11/2018: Virtudent venture capital transaction
Next: 7/11/2018: Bay Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs